# FDA Inspection 1265662 - Jiangsu Weiqida Pharmaceutical Co., Ltd. - March 21, 2025

Source: https://www.keypedia.com/records/fda_inspections/jiangsu-weiqida-pharmaceutical-co-ltd/7d9da020-6a1f-4404-9a66-c326e2e70c53
Source feed: FDA_Inspections

> FDA Inspection 1265662 for Jiangsu Weiqida Pharmaceutical Co., Ltd. on March 21, 2025. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1265662
- Company Name: Jiangsu Weiqida Pharmaceutical Co., Ltd.
- Inspection Date: 2025-03-21
- Product Type: Human Drugs
- Office Name: Office of Inspections and Investigations

## Related Documents

- [FDA Inspection 1265662 - 2025-03-21](https://www.keypedia.com/records/fda_inspections/jiangsu-weiqida-pharmaceutical-co-ltd/f42253c9-3439-4f8f-9702-8a649237f0b5)
- [FDA Inspection 1038055 - 2017-12-15](https://www.keypedia.com/records/fda_inspections/jiangsu-weiqida-pharmaceutical-co-ltd/ab5f8eda-6119-432b-8290-67fa2cfe855a)
- [FDA Inspection 880208 - 2014-04-30](https://www.keypedia.com/records/fda_inspections/jiangsu-weiqida-pharmaceutical-co-ltd/434a52c1-dc93-494d-9c3e-f15133ae87f0)

Company: https://www.keypedia.com/companies/jiangsu-weiqida-pharmaceutical-co-ltd/3210bab8-b3e8-495f-9a42-02405bb691f7

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8